Zydus Lifesciences Shares Surge 4% on USFDA Final Approval
Shares of Zydus Lifesciences increased 3.8% to Rs 1156 on Wednesday, 28 August, after the company announced receiving final approval from the US Food and...
Tag : US Food and Drug Administration (USFDA)
Wanbury Shares Surge 5% on Receiving Form 483 With Zero Observation
Shares of Wanbury Ltd surged 5% on 23 August after the company announced receiving an Establishment Inspection Report (EIR) with zero form 483 observations from...
Aurobindo Pharma Shares Drop 6% after Eugia unit-III receives USFDA warning letter
Shares of Aurobindo Pharma Ltd. dropped 6% after touching a day’s high of Rs 1,527 on 16th August, following the company’s disclosure that its Eugia...
Granules India Shares Rise 2% After USFDA Approval for Antidepressant Drug
Shares of Granules India Ltd. rose by nearly 2% to touch a day’s high of Rs 666.30 on 9th August after the USFDA approved its...
Caplin Point Labs Arm Gets USFDA Approval for Timolol Maleate; Shares Drop 7%
Shares of Caplin Point Laboratories Ltd. dropped 7% after touching a day’s high of Rs 1,611.80 on 8th August, despite the company’s subsidiary receiving final...
Alembic Pharma Secures USFDA Approval for Cancer Drug; Shares Gain 3%
Shares of Alembic Pharmaceuticals Ltd were trading in the green and 3% higher on 2 August after the company announced securing final approval from the...
Sun Pharma Receives USFDA Approval for Alopecia Treatment Drug; Shares Jump 3%
Shares of Sun Pharmaceutical Industries Ltd. surged by almost 3% to touch a day’s high of Rs 1,712.40 on 26 July after announcing USFDA approval...
Gland Pharma Shares Slip 2% as USFDA Issued 2 Observations
Shares of Gland Pharma Ltd slipped 2% and hit an intra-day low of Rs 1,978.40 on 25 July after the company announced that the US...
Jubilant Pharmova Shares Slump 4% as Canada Facility Receives VAI Status from USFDA
Shares of Jubilant Pharmova slumped 4% on 22 July after the company’s Canada plant as having a “voluntary action indicated” (VAI) status by the US...
Zydus Lifesciences Shares Slumped 3% as Jarod Unit Received OAI Classification
Shares of Zydus Lifesciences were trading in the red and 3% lower on 19 July after the company announced that its Jarod unit received OAI...